| Title |
Date |
| As 5th Anniversary Of 9/11 Approaches, Public Confidence In Government Drops |
09/14/06 |
|
On the eve of the fifth anniversary of the September 11th attacks, the American public's confidence in the ability of the U.S government to protect them from terrorism, or respond to disasters or emergencies, has dropped to startling new lows, according |
| Clean Water Project Hit By Funding Drought |
09/14/06 |
|
British engineers have developed a simple water filter which could save thousands of lives in developing countries. |
| Sapporo Breweries And Sapporo Beverages Show Sapporo Drinks Alleviate Hay Fever Symptoms |
09/14/06 |
|
Sapporo Breweries Ltd., and Sapporo Beverages Co., Ltd. have proven that Sapporo beer is effective in mitigating hay fever symptoms. Hop flavonol glycoside extracted from the beer prevents histamine, an allergy-inducing substance. |
| Cancer And Psoriasis can be aggravated by "Allergy Cells" |
09/14/06 |
|
The body's mast cells are mainly associated with allergic reaction in the way they release histamine and other inflammatory substances. However, researchers at Karolinska Institutet have now demonstrated how the mast cells can also contribute to diseases |
| Promising Preclinical Results With Live Attenuated H5N1 Vaccines |
09/14/06 |
|
Several approaches are in progress to develop vaccines against the avian flu variety of the influenza virus. Kanta Subbarao (National Institutes of Health) and colleagues are working on live attenuated vaccines, which have the potential to elicit a stron |
| Live H5N1 Avian Flu Virus Vaccines Show Protection In Animal Studies |
09/14/06 |
|
When tested in mice and ferrets, experimental vaccines based on live, weakened versions of different strains of the H5N1 avian influenza virus were well-tolerated and protected the animals from a deadly infection with naturally occurring H5N1 flu viruses |
| New Multi-year Funding Will Allow International Group To Unravel Carbohydrate Mysteries |
09/14/06 |
|
The Consortium for Functional Glycomics was formed in response to the NIGMS announcement that it would provide glue grants to support multi-disciplinary, multi-institutional research projects that would be considered beyond the means of any one group. Th |
| INEGYT Is Superior To Simvastatin In Reducing Key Risk Markers Of Atherosclerosis - Confirmed |
09/14/06 |
|
Results from new analyses of two clinical studies presented today at the 2006 World Cardiology Congress show that INEGY™ (ezetimibe/simvastatin) is effective for reducing apolipoprotein-B containing lipoproteins (apo-B) and C-reactive protein (CR |
| New Study Demonstrates Dietary Supplement Lutein Increases Skin Hydration, Elasticity And Lipid Levels |
09/14/06 |
|
Highlights from a new clinical study presented today at the "Beyond Beauty Paris" conference in France provide compelling evidence that lutein, a dietary nutrient
available as a supplement and long-known for its effectiveness in promoting
eye health, |
| Ortec Announces Positive Results In Confirmatory Venous Leg Ulcer Trial |
09/14/06 |
|
Ortec International, Inc. (OTC Bulletin Board: OTCI), a company focused on advancing regenerative medicine through the development of cellular technology and advanced
biomaterial products, announced today that a preliminary review of the un-
audited d |
| Synta Pharmaceuticals Announces Phase 2 Trial Data Showing STA-4783 Doubles Median Progression-Free Survival In Metastatic Melanoma |
09/14/06 |
|
Synta Pharmaceuticals Corp.,
a biopharmaceutical company focused on discovering, developing, and
commercializing small-molecule drugs to treat severe medical conditions,
today announced positive data from a Phase 2b study in metastatic melanoma
for |
